Deep Intelligence Across Industries

Company Headquarters: US Founded: 1906 Workforce: ~35,000 Company Working: Xerox Corporation (Xerox) is a print technology and intelligent work solutions leader focused on helping people communicate and work better. The company implements their expertise in imaging and printing, data analytics, and the development of secure and automated solutions to help its customers to improve productivity and increase client satisfaction. The primary offerings spread across three main areas, managed document services, workplace solutions, and graphic communications. The managed document services offerings help customers, ranging from small Businesses to global enterprises, optimize their printing and related document workflow and Business processes. Xerox led the establishment of its expanding market and continues as the industry leader. The Workplace Solutions and Graphic Communications products and solutions support the work processes of its customers by providing them with efficient and cost-effective printing and workflow solutions. The company operates globally.

Company Headquarters: Germany Founded: 1994 Workforce: ~316,901 Company Working: Deutsche Bahn is a German railway company. It is the second-largest transport company in the world, after the German postal and logistics company Deutsche Post / DHL, and is the largest railway operator and infrastructure owner in Europe. The company operates through three group subsidiaries, namely Personenverkehr, Infrastructure, and logistics. These groups perform their tasks under multiple subsidiaries. DB Personenverkehr group is divided into three Business areas: DB Fernverkehr, DB Regio and Arriva. Arriva runs Bus and rail companies in 12 European countries. DB Fernverkehr AG is a semi-independent division of Deutsche Bahn that operates long-distance passenger trains in Germany. DB Fernverkehr operates all InterCityExpress and InterCity trains in Germany as well as in some neighboring countries and several EuroCity and EuroCityExpress trains throughout Europe. DB Regio AG is the subsidiary of Deutsche Bahn that operates passenger trains on short and medium distances in Germany. The infrastructure segment is divided into DB Netz (rail infrastructure), DB Station&Service (stations and services) and DB Energie (Energy) Business units. The logistics unit operates the DB Schenker and DB Cargo segments. The company operates globally.

BMW Group is the world's largest premium automotive manufacturer by volume and the only major German OEM to have entered the 2026 downturn with a completed, purpose-built next-generation electric architecture already in series production. It sells roughly 2.5 million cars and 200,000 motorcycles annually through four automotive brands — BMW, MINI, Rolls-Royce and, from January 2026, BMW ALPINA — plus BMW Motorrad, supported by a large captive finance arm that penetrates over half of new-vehicle deliveries. Its defining strategic wager is *technology openness*: a single flexible architecture family carrying combustion, plug-in hybrid, battery-electric and, from 2028, hydrogen fuel-cell drivetrains, allowing regional demand to be served without stranded capital. That wager has protected fleet-CO₂ compliance and European share, but has not insulated the company from a structural collapse in Chinese premium demand, from US and EU tariffs, or from the margin compression that forced a 2026 guidance reset and the largest voluntary redundancy programme in its history. --- ### The company's own characterisation BMW Group describes itself, in the standard boilerplate appended to every 2025 and 2026 press release, as follows: with its four brands BMW, MINI, Rolls-Royce and BMW Motorrad, the BMW Group is the world's leading premium manufacturer of automobiles and motorcycles and also provides premium financial services; its production network comprises over 30 production sites worldwide and it maintains a global sales network in more than 140 countries. In 2025 it sold 2.46 million passenger vehicles and more than 202,500 motorcycles, generating profit before tax of €10.2 billion on revenues of €133.5 billion, with 154,540 employees at year end. The company states that its economic success "has always been based on long-term thinking and responsible action," and that sustainability is a core element of corporate strategy across the full product life cycle from supply chain through production to end of use. In the 2025 Group Report, management framed the year as a demonstration of resilience: tariffs, currency movements and intense competition — particularly in China — "shaped the year and demanded both flexibility and discipline," while the Automotive segment nonetheless landed an EBIT margin within its then-guided range and the Group held a stable 7.7% pre-tax margin. ### Independent characterisation BMW is best understood as three economically distinct businesses bolted onto one brand system, and the distinction matters enormously for analysis: **(a) An industrial premium vehicle manufacturer.** The Automotive segment generated €117,557 million of revenue in FY2025 (88.1% of gross segment revenue before eliminations) and is the sole source of the Group's product differentiation. It is a capital-intensive, fixed-cost-heavy business with a five-to-seven-year model cycle, exposed to raw materials, currency translation, tariffs and regulatory fleet-CO₂ regimes. Its economics are volume-times-mix-times-price less a largely fixed industrial base — which is precisely why a 4.2% delivery decline in H1 2026 translated into a 45.6% EBIT decline in the segment. **(b) A captive bank and leasing company.** The Financial Services segment generated €39,806 million of revenue in FY2025 and €2,401 million of pre-tax profit. It writes retail credit and lease contracts, dealer floorplan financing, insurance brokerage and fleet management (Alphabet), and takes deposits through BMW Bank GmbH. Its balance sheet — €60,985 million of leased products and €90,193 million of sales-financing receivables at 31 December 2025 — dominates Group assets and Group gross debt. Any Group-level leverage or net-debt metric for BMW is therefore economically meaningless without segmenting out Financial Services. Financial Services is also the transmission mechanism for used-car residual value risk, which is the single most under-appreciated earnings variable in the 2026 guidance. **(c) A motorcycle business.** BMW Motorrad generated €3,143 million of revenue and €178 million of EBIT in FY2025 — approximately 2% of revenue. Small, but structurally higher-margin in the seasonally strong quarters (Q2 2026 EBIT margin 15.2%) and strategically useful as a brand halo. ### Revenue model and mix BMW's revenue is overwhelmingly product sale revenue recognised at delivery, not subscription or licensing. The approximate FY2025 split of consolidated Group revenue by activity, as reconstructed from segment disclosure, is: vehicle sales ~73%, financial services (interest income, lease income, insurance commission, end-of-lease resale) ~25%, motorcycles ~2%. BMW has deliberately not pursued the aggressive software-subscription model attempted by some peers; connected services, ConnectedDrive upgrades and Functions on Demand exist but are not separately material and are not disclosed as a discrete revenue line. Two features of the revenue model deserve emphasis: **Resale of end-of-lease vehicles is revenue, not a memo item:** A significant portion of Financial Services revenue is the gross proceeds of remarketing returned lease vehicles. Falling used-car prices therefore hit revenue and margin simultaneously — explicitly cited by management as a 2026 headwind. **Penetration is rising sharply:** The share of new BMW Group vehicles leased or financed by the captive rose from 42.6% in FY2024 to 46.6% in FY2025, and further to 52.9% in H1 2026 (from 43.7% in H1 2025). New contracts written rose 5.0% year on year to 866,088 in H1 2026. This is a demand-support mechanism — subvented finance — and it transfers risk from the industrial P&L onto the captive's residual-value book. ### Value chain position and customers BMW occupies the OEM tier: it designs, engineers, assembles and brands, purchasing roughly €79.5 billion of goods and services in 2025 (Group purchase volume, per the 2025 Group Report). It has integrated selectively upstream into battery pack assembly (not cell manufacture — cells are bought from CATL, EVE Energy and Envision AESC) and downstream into finance, but not into retail: the vast majority of deliveries are made by independent third-party dealers. Customer types are (i) retail private buyers, (ii) corporate and fleet customers (a large European channel, served through Alphabet), (iii) dealers themselves for demonstrator and loaner stock, and (iv) in the US and Canada specifically, dealers and third parties acquiring company vehicles at auction, which BMW counts as deliveries under its published definition. End-markets served: premium and luxury passenger vehicles (compact through ultra-luxury), premium motorcycles, and automotive financial services. The Group does not participate in mass-market vehicles, commercial vehicles or heavy trucks — a notable structural difference from Mercedes-Benz Group (Vans) and Volkswagen Group.

Daimler AG, founded in 1926 through the merger of Benz & Cie. and Daimler-Motoren-Gesellschaft, restructured in 2021 by spinning off its commercial vehicle operations into Daimler Truck Holding AG, a separately listed entity on the Frankfurt Stock Exchange. The parent company subsequently rebranded as Mercedes-Benz Group AG, retaining the passenger car and van businesses. Within the heavy Equipment and Utility Vehicles Market, Daimler's commercial vehicle legacy — now carried by Daimler Truck Holding — encompasses heavy-duty trucks, specialty vehicles, and purpose-built utility platforms manufactured and sold across North America, Europe, Asia, and Latin America through brands including Mercedes-Benz Trucks, Freightliner, Western Star, FUSO, and BharatBenz. Daimler Truck Holding's portfolio in the high equipment and utility vehicles segment spans Class 6–8 heavy trucks, vocational vehicles, and specialty utility configurations used in construction, mining logistics, municipal services, and long-haul freight. Freightliner commands the largest share of the North American Class 8 truck market, consistently ranking as the top-selling heavy-duty truck brand in the United States. Western Star serves the severe-duty and vocational segment, supplying vehicles to construction fleets, oil-field operators, and municipal agencies that require high-payload, off-road-capable platforms. Mercedes-Benz Trucks addresses European and global markets with the Actros, Arocs, and Econic lines, where the Arocs is specifically engineered for construction and heavy haulage applications. Following the 2021 demerger, Daimler Truck Holding has pursued an independent strategic agenda centered on electrification and autonomous driving for commercial and utility applications. The company launched the Freightliner eCascadia and the Mercedes-Benz eActros 600 for long-haul duty cycles, and it established the Torc Robotics partnership — in which Daimler Truck holds a majority stake — to develop SAE Level 4 autonomous truck technology. In 2023, Daimler Truck entered a joint venture with PACCAR and Aurora Innovation to accelerate autonomous freight deployment, directly targeting the heavy commercial and utility vehicle corridors in North America. The company also deepened its hydrogen fuel-cell truck development through the cellcentric joint venture with Volvo Group, targeting zero-emission heavy utility applications by the late 2020s. Daimler Truck Holding reported group revenue of approximately €55.9 billion for fiscal year 2024, with the Trucks North America segment — anchored by Freightliner and Western Star — contributing the largest share of earnings. Key customer segments in the heavy Equipment and Utility Vehicles Market include national and regional fleet operators, construction and infrastructure contractors, municipal governments procuring refuse and utility trucks, and energy-sector logistics providers. Freightliner's sustained market leadership in North American Class 8 sales and Western Star's dominance in severe-duty vocational applications position Daimler Truck as the highest-volume participant in the North American heavy and utility vehicle segment.

### 1.1 Positioning statement Amazon is no longer usefully described as a retailer. On FY2025 revenue of USD 716.9 billion it is the largest company in the world by sales, but the economics of the enterprise are governed by three businesses that did not exist at the IPO: Amazon Web Services, which produced 18.0% of FY2025 revenue and 57.0% of FY2025 consolidated segment operating income; advertising services, which grew 22% in FY2025 to USD 68.6 billion at a margin the company declines to disclose but which is structurally superior to first-party retail; and a third-party marketplace that now carries 61% of paid units and monetizes through commissions, fulfilment fees, and ads rather than inventory arbitrage. Retail is the customer-acquisition engine and the logistics moat; AWS and advertising are the profit pools. As of mid-2026 the company is executing the largest single-year capital programme in corporate history — approximately USD 220 billion of 2026 capital expenditure, raised from USD 200 billion in February — financed by more than USD 89 billion of 2026 bond issuance, and has driven trailing free cash flow to an outflow of USD 7.6 billion. The strategic wager is that AI compute demand is durable enough to convert that capital base into a second AWS-scale margin engine. --- ### 2.1 The company's own characterization Amazon states in its earnings releases that it is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. The company describes its aspiration as being Earth's Most Customer-Centric Company, Earth's Best Employer, and Earth's Safest Place to Work, and identifies as its own inventions customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge (Q2 2026 press release, "About Amazon"). In the FY2025 Form 10-K, management frames its financial model around a distinction between variable and fixed costs. Variable costs — product and content costs, payment processing, picking, packing, transportation, customer service, the costs required to run AWS, and a portion of marketing — change directly with volume. Fixed costs — technology infrastructure, store and web-services development, and fulfilment network build-out — are driven by the timing of capacity needs, geographic expansion, and category expansion. The stated objective is to reduce variable cost per unit while leveraging fixed costs across a growing revenue base. ### 2.2 Independent characterization Amazon operates four economically distinct businesses inside a three-segment reporting structure. **First-party retail.** Amazon buys inventory and sells it at gross revenue recognition. FY2025 online stores revenue was USD 269.3 billion and physical stores USD 22.6 billion. This is a low-margin, working-capital-negative business: at FY2025 year-end, days payable outstanding of approximately 125 days against days inventory outstanding of approximately 39 days produced a cash conversion cycle of roughly negative 51 days, meaning suppliers finance the inventory. Amazon was named the lowest-priced US retailer by Profitero for a ninth consecutive year, with online prices averaging 14% below other major US retailers (FY2025 Q4 press release; reiterated in Q2 2026). **Third-party marketplace and fulfilment services.** Amazon rents its demand aggregation, fulfilment, and delivery network to independent sellers, recognizing only commissions and fees as revenue. FY2025 third-party seller services revenue was USD 172.2 billion, and third-party sellers accounted for 61% of worldwide paid units in Q4 2025 and Q2 2026. The revenue is a fraction of the gross merchandise value transacted, but it is materially higher-margin than first-party retail because Amazon carries no inventory risk. **Advertising.** FY2025 advertising services revenue was USD 68.6 billion, up 22%; Q2 2026 revenue was USD 19.8 billion, up 26%. This is sponsored product placement, display, and video inventory sold to sellers, vendors, publishers and authors. It is a demand-side monopoly rent on the marketplace: sellers who need visibility on Amazon have no substitute channel of comparable intent quality. Amazon does not disclose advertising segment margins, but the business is embedded in North America and International segment income and is the principal reason North America operating margin expanded from 2.6% in FY2021 to 7.0% in FY2025. **Amazon Web Services.** FY2025 revenue USD 128.7 billion at a 35.4% operating margin; Q2 2026 revenue USD 42.2 billion at a 39.4% operating margin and a USD 169 billion annualized run rate. AWS sells compute, storage, database, networking, analytics, machine learning, and — increasingly — foundation-model access and custom silicon. It is a consumption-priced utility with multi-year committed contracts, and it is the single most important variable in the equity story. ### 2.3 Revenue model mix Source: FY2021–FY2025 Forms 10-K, Consolidated Statements of Operations. The mix shift from products to services is the single clearest structural signal in Amazon's accounts: 41.3% of FY2025 revenue was gross-recognized product sales versus 51.5% four years earlier. Every incremental point of services mix carries higher gross margin. ### 2.4 Customer types and end-markets Amazon defines four customer constituencies in its filings: consumers, sellers, developers/enterprises, and content creators. Consumer end-markets span effectively all general merchandise categories plus grocery, pharmacy, and digital media. Seller customers are small and medium businesses and brands worldwide. Enterprise customers of AWS span every vertical: FY2025 and H1 2026 disclosed AWS agreements include OpenAI, Visa, BlackRock, United Airlines, DoorDash, Salesforce, Adobe, Thomson Reuters, AT&T, S&P Global, HSBC, London Stock Exchange Group, Accenture, CrowdStrike, the U.S. Air Force, Warner Bros. Discovery, Vodafone, Siemens Energy, Ryanair, Pinterest, Snowflake, Moody's, Danske Bank, Fiserv, WPP Enterprise Solutions, the NBA, the NFL, the WNBA, the New York State Office of Information Technology Services, the State of Iowa, the University of South Florida, and The University of Utah. ### 2.5 Value chain position Amazon is unusually vertically integrated for a platform business. It owns the demand aggregation layer (amazon.com and country storefronts), the merchandising and pricing layer, the fulfilment network (fulfilment centres, sortation centres, delivery stations), the middle-mile and last-mile transportation network (Amazon Air, line-haul trucking, Delivery Service Partners, Amazon Flex), the payment layer, the advertising exchange, the cloud infrastructure layer including custom silicon (Graviton, Trainium, Inferentia, Nitro), the device layer (Echo, Fire, Kindle, Ring, eero, Blink), the content layer (Prime Video, MGM, Amazon Music, Audible, Twitch), and — pending completion of the Globalstar acquisition — a satellite connectivity layer. In FY2026 it began selling the fulfilment layer itself as a standalone product through Amazon Supply Chain Services, with Procter & Gamble, 3M, Lands' End, and American Eagle Outfitters as launch customers. ---

Company Headquarters: California, US Founded: 1970 Workforce: ~100 Company Working: FUJIFILM Irvine Scientific operated as a subsidiary of Fujifilm Corporation as of June 2018. It is a renowned leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company operates dual cGMP manufacturing facilities in California and Tokyo. It offers a broad range of prenatal, diagnostics, & cytogenetics products, reproductive media products, classical media products, and culture media solutions.

Monash IVF Group is one of Australia's two largest private providers of assisted reproductive services (ARS). It ranked #2 nationally by stimulated-cycle market share in 1H26 (company presentation), with about 19.5–20.2% of the domestic stimulated-cycle market in FY26. The group combines three businesses: - IVF clinics across every mainland state - An integrated reproductive genetics laboratory - Specialist women's ultrasound practices in Victoria, NSW and WA A growing South-East Asian network in Malaysia, Singapore and Indonesia adds to this. The company's heritage reaches back to the Monash University team behind several of the world's earliest IVF milestones in the 1970s and 1980s. That scientific legacy remains central to its brand. Since 2025, the investment case has been reshaped by four factors: - Two embryo-transfer incidents - A wholesale leadership and board renewal - A cyclical slowdown in domestic IVF demand - Two rejected control proposals from a consortium of WHSP and Genesis Capital, which holds about 19.6% The new CEO, Dr Victoria Atkinson, is executing the "Nurture 2030" plan. --- ### Company's own description In the FY26 Directors' Report, Monash IVF describes itself as a leader in human fertility services and one of the leading ARS providers in Australia and South-East Asia. It notes that ARS is the most significant component of fertility care. It describes ARS as the range of techniques used to help infertile patients achieve a clinical pregnancy, including reproductive genetic services. It adds that the Group is also a significant provider of specialised women's imaging and diagnostic services (paraphrased from FY26 Financial Report, "Principal activities"). ### Independent characterisation | End-market | Description | |---|---| | Australian ARS | Core. About 92% of group revenue (Australian segment, FY26). | | Australian women's imaging | Obstetric and gynaecological ultrasound | | Reproductive genetics | PGT, carrier screening, NIPT | | South-East Asian ARS | International segment, about 8% of revenue | Monash IVF is a vertically integrated, clinic-based healthcare services operator. Its economics resemble a hybrid of specialist day-hospital operator, laboratory business and consumer-facing elective health brand. **Revenue mix.** Revenue is overwhelmingly service revenue. There is no product, subscription or licensing revenue of note. It comprises: - Patient fees for IVF cycles: stimulated cycles, frozen embryo transfers (FETs), donor and surrogacy programs, and egg freezing - Embryology laboratory services - Day-surgery facility fees (egg pick-ups and related procedures) - Genetics testing: PGT-A, PGT-M, PGT-SR, carrier screening and NIPT - Embryo, egg and sperm storage fees - Ultrasound scan fees **Doctor relationships.** Fertility specialists are largely independent practitioners who refer into and practise within Monash facilities. Doctor attraction and retention is therefore the single most important lever on volumes. In FY26, 13 new specialists and 3 trainees joined (FY26 presentation). **Payers.** In Australia, patients receive partial reimbursement through the Medicare Benefits Schedule (MBS items 13200/13201 for stimulated cycles) and the Extended Medicare Safety Net. Out-of-pocket costs are material, so the business carries a consumer-affordability sensitivity. Management has argued that this relationship is not linear (FY26 results commentary reported by AAP). Private health insurance covers some hospital components. **Value chain position.** Monash owns the clinic and laboratory infrastructure, the day hospitals, the genetics lab and the ultrasound practices. It sources consumables, culture media, embryoscopes and pharmaceuticals from third-party suppliers. Electronic witnessing technology (Matcher®) was being rolled out in FY25. **Customer types:** - Couples and individuals with infertility - Same-sex couples and single women (donor programs) - Fertility-preservation patients (elective egg freezing; oncology) - Pregnant women (obstetric and gynaecological ultrasound, NIPT) - Carrier-screening patients - International medical tourists in South-East Asia, especially Johor Bahru and Bali **End-markets.**

Company Headquarters: Sweden Founded: 1994 Workforce: ~400 Company Working: Vitrolife is renowned as one of the leading providers of IVF laboratories with high-quality products. It offers a broad range of products for the preparation, cultivation, and storage of human cells, tissues, and organs which include needles, pipettes, incubators, and laser & imaging systems, among others. It operates through four business units including media, time-lapse, disposable devices, and art equipment. It runs production facilities in over ten countries worldwide.

Kureha is a mid-cap Japanese specialty chemicals and plastics maker with a strong technology base. It sells about ¥162bn a year and has built global niche positions from in-house polymer and carbon chemistry. **Advanced Materials:** holds most of its strategic value: - PVDF (polyvinylidene fluoride), used mainly as a cathode binder in lithium-ion batteries; - PPS resin through its 50:50 US joint venture with Celanese (Fortron Industries); - PGA (polyglycolic acid) dissolvable frac plugs for US shale gas; - pitch-based carbon fibre and bead-shaped activated carbon. **Specialty Plastics:** contributes stable, high-margin cash flow from the household franchise NEW Krewrap and Seaguar fluorocarbon fishing line. **Specialty Chemicals:** combines regional chlor-alkali and chlorobenzene chemistry with a small life-science arm: the fungicides metconazole and ipconazole, the kidney drug Kremezin, and a pipeline led by the fungicide carmeconazole. After a PVDF-led capex cycle failed when EV demand slowed, Kureha took ¥36.5bn of impairments in FY2025. It has since reset its strategy around a three-pillar portfolio, targeting ROE of 8% by FY2028 and 12% by FY2035. --- **Company's own description.** The FY2025 Summary describes the Kureha Group as manufacturing and selling advanced materials, chemical materials and specialty plastics as its core business. It also provides construction and facility repair for its segments, logistics, environmental solutions and other services. The corporate vision (2023) is to be "a specialty solutions company that leverages proprietary technology and contributes to a new future for society." The FY2035 plan restates the aim as becoming "a high-value-added company committed to driving value through technology and competing globally." **Business model.** Kureha is overwhelmingly a product company: - Revenue is recognised on shipment of resins, compounds, processed parts (PGA frac plugs), films, consumer goods, agrochemical active ingredients and formulations, a pharmaceutical, and commodity chlorine chemicals. - Service revenue comes from two places: - the Construction segment (Kureha Construction, mostly external civil and building contracts plus internal plant work); - **Other Operations**, which covers industrial waste treatment (Kureha Ecology Management), analysis and testing, logistics (Kureha Unyu) and medical services. - Together these service businesses made up about 21% of FY2025 external revenue (¥34.2bn of ¥161.7bn). - Licensing and royalties are not separately disclosed. Agrochemical active ingredients are commercialised largely through partner distribution and licensing arrangements, but royalty income is not broken out. - There is no subscription revenue. **Value-chain position.** - Kureha is vertically integrated from basic chlorine chemistry at Iwaki (caustic soda, hydrochloric acid and chlorinated aromatics) into fluoropolymer and chlorinated-polymer monomers. These monomers feed PVDF and PVDC (Krehalon/Krewrap). - It is a mid-stream materials supplier to battery cell makers (PVDF binder), compounders and auto/electronics component makers (PPS), and oilfield service companies and E&Ps (PGA plugs). - It is a downstream brand owner in Japanese household consumables (NEW Krewrap) and global fishing line (Seaguar). - In crop protection it acts as an originator of active ingredients and partners with distributors. **Customer types and end-markets.** - Battery cell makers: Japan, Korea and China customers for automotive NMC/LFP and energy storage systems (ESS). - Automotive and electronics tier suppliers, including PPS for optical communication components in data centres. - US shale oil and gas operators (Haynesville, Appalachia, Eagle Ford, Bakken, Permian), with planned exports to Argentina and the Middle East from FY2026. - Global agrochemical distributors. - Japanese nephrology practices and wholesalers (Kremezin). - Japanese retailers (home products). - Global anglers and tackle distributors (Seaguar). - Meat and cheese processors (Krehalon PVDC barrier film and bags; the European multilayer heat-shrink film business was exited in 2024). - Japanese municipalities and industry (waste treatment, construction). **Independent characterisation.** Kureha is best described as a portfolio of niche technology franchises attached to a regional chemical and services base: - Its profit pool is unusually concentrated in a few products. In FY2025, Specialty Plastics generated about 48% of segment core operating profit on 23% of revenue (LTMP 2035). - Its growth narrative from 2021 to 2024 rested on a single application: PVDF binder for automotive NMC batteries. - When that application faltered, through EV subsidy cuts in Europe and the US and a market shift to LFP chemistry, the economics of a ¥66–70bn capacity expansion collapsed. - The company is now an earnings-recovery and capital-allocation story. Investors are asking whether PGA can return to profit, whether PVDF can fill a new 8,000 t/y plant from 2027, and whether a long-dated life-science pipeline can rebalance the portfolio by 2035.

Tosoh is one of Asia's largest chlor-alkali producers. It is a vertically integrated Japanese chemical group that uses two highly integrated complexes, Nanyo (Yamaguchi) and Yokkaichi (Mie), to run product chains starting from salt electrolysis and naphtha cracking. Those chains feed into caustic soda, VCM/PVC, MDI/HDI urethanes, polyethylene, chloroprene rubber and cement. On top of this commodity base, Tosoh has built a portfolio of high-margin "advanced" businesses: - bioscience: chromatography media and HbA1c and immunoassay diagnostics; - advanced materials: zirconia, high-silica zeolite, quartz glass, sputtering targets and electrolytic manganese dioxide; - ultrapure-water engineering for leading-edge semiconductor fabs, through its listed subsidiary Organo. In FY2026 these advanced businesses generated about two-thirds of group operating income on roughly 37% of sales. The investment case rests on that barbell: cyclical, cash-generative chlorine and olefin chains that are exposed to Chinese oversupply and naphtha shocks, paired with structurally growing semiconductor and life-science franchises. Capital returns are anchored by a ¥100 dividend floor and a 50% total payout policy. --- ### What the company does Tosoh makes and sells basic chemicals, petrochemicals, fine and specialty chemicals, diagnostics and analytical instruments, electronic materials, and water-treatment systems. JCR's July 2025 rating rationale describes the group in two parts: **Chemical Chain Business:** This produces everything from basic chemicals (olefins, polymers, chemicals, urethanes, cement) to value-added chemicals (functional polymers, functional urethanes, organic chemicals). Production is organized as one integrated product chain that starts from salt electrolysis and naphtha cracking. **Advanced Technologies Business:** This covers bioscience, advanced materials and water treatment. It relies on the infrastructure, utilities and technological base of the chain business. The company's own description in its English releases is that it is "one of the largest chlor-alkali manufacturers in Asia." It supplies plastic resins and basic chemicals, runs petrochemical operations (ethylene, polyethylene, functional polymers), and serves the semiconductor, display and solar industries through advanced materials. Its bioscience systems are used to monitor life-threatening diseases. ### Business model and revenue model | Revenue type | Where it arises | Characterization | |---|---|---| | Product sales, priced off commodity indices | Olefins, PVC/VCM, caustic soda, MDI, cement, polyethylene | Volume times price. Prices track naphtha, Asian spot markets and USD/JPY; margins track "terms of trade" and inventory valuation gains or losses. | | Specialty product sales | Chloroprene rubber, HDI hardeners, ethyleneamines, bromine, zirconia, zeolite, quartz glass, sputtering targets, EMD | Contract or negotiated pricing with higher value-add. Some products (quartz, targets) are tied to semiconductor capex and wafer-start cycles. | | Razor/blade consumables and instruments | Bioscience: chromatography media (TSKgel, TOYOPEARL), diagnostic reagents, HbA1c and immunoassay analyzers | Recurring reagent and media revenue on an installed base. JCR cites bioscience as having "established recurring revenue models." | | Project engineering (percentage of completion) | Water-treatment engineering (Organo): ultrapure-water plants for semiconductor fabs in Japan, Taiwan and the US | Lumpy project revenue plus recurring "solutions": equipment-ownership services and maintenance. | | Services | Logistics, warehousing, inspection and analysis, IT, construction and repair ("Other") | Captive or near-captive service revenue. | Tosoh does not disclose a product/service/subscription/licensing split. Our independent estimate is directional only: well over 75% product sales, about 15–18% project engineering and services (water treatment plus other), and negligible licensing revenue. ### Value-chain position Tosoh sits upstream to midstream. It converts salt, purchased naphtha and coal-fired captive power into intermediates (caustic soda, chlorine, ethylene, VCM, MDI) and resins, and it consumes much of its own chlorine and ethylene internally. Its advanced businesses sit further downstream as component and consumable suppliers to: - semiconductor fabs and equipment makers (quartz glass, sputtering targets, ultrapure water); - biopharma (purification resins); - clinical laboratories (diagnostics); - dental and decorative ceramics (zirconia); - automotive emissions control (zeolite). ### Customer types and end-markets Customers include PVC fabricators, construction and infrastructure contractors, automotive tier-1 suppliers, coatings and adhesives makers, tire and industrial rubber makers, foam producers, semiconductor fabs and toolmakers, display makers, biopharmaceutical manufacturers, hospitals and clinical labs, dental laboratories, and battery makers. Principal end-markets are construction and housing, automotive, electronics and semiconductors, healthcare and pharma, and general industry. Sales split almost evenly between Japan (49.6%) and overseas (50.4%) in FY2026. ### Independent characterization Tosoh is best understood as a low-cost, scale-integrated Asian chlor-alkali and urethane producer that has used its cash flows to compound three genuinely differentiated niches: - bioscience separations and diagnostics, with a segment operating margin of about 28% in FY2026; - semiconductor water engineering, at about 21.5%; - engineered ceramics and catalysts. The commodity chain sets the volatility of earnings; the advanced businesses set the floor. FY2026 illustrated this clearly. Basic Materials earned only about JPY 0.1bn of operating income on JPY 450bn of sales (restated), while the advanced businesses earned about JPY 64bn.

Company Headquarters: Turkey Founded: 1935 Workforce: 21,327 Company Working: Şişecam Group is an industrial group conducting operations on an international scale in the fields of flat glass, glassware, glass packaging, and chemicals. Şişecam carries out its production activities at 43 production facilities in 13 countries and selling its products in over 150 countries. The international sales constitute more than half of the Group’s total sales. Şişecam is Turkey’s leader in all types of glass products as well as chemicals including soda-chromium compounds. It offers sodium bicarbonate under its chemicals segment.

Company Headquarters: Warsaw, Poland Founded: 1945 Workforce: ~3,000+ Company Working: Ciech group is a manufacturer and distributor of soda ash, glass, and chemical-based products. The four segments of the company are based on product type and function. The majority of revenue is generated by the Soda division, which sells soda ash used in the production of glass, detergents and chemicals. Agro Section manufactures crop protection products for agricultural use. Epoxy resins and polyester resins are produced by the resins section. The Foams Segment manufactures polyurethane foams, which are mostly utilized in the furniture industry for upholstered furniture and mattresses. The Silicates Segment produces sodium and potassium silicates. The packaging division produces glass packaging lanterns and jars for use in the food industry as well as headstone lamps. CIECH manufactures sodium bicarbonate under the SOBIC brand in factories in Germany and Poland. CIECH is one of the major manufacturers in the European Union, with a total manufacturing capacity of around 200 thousand tonnes per year. The Group's sodium bicarbonate has a wide range of applications, including the food sector (SOBIC Food), pharmaceutical and cosmetics industries (SOBIC Health Care), feed (SOBIC Feed), chemical (SOBIC Tec), and energy industries (flue gas purification).

Company Headquarters: Mumbai, India Founded: 1939 Workforce: ~5,000 Company Working: Tata Chemicals Ltd. develops and distributes a wide range of chemicals and agricultural products. The company is divided into three reportable segments: Soda ash, marine chemicals, caustic soda, cement, bulk chemicals, and salt are examples of inorganic chemicals. Agri inputs include exchanged seeds, insecticides, specialty crop nutrients, and fertilizers. Additional products include pulses, spices, water purifiers, and nutritional supplements. Basic Chemistry product line of the company supplies critical ingredients to many of the world's leading brands in glass, detergents, medicines, biscuit making, bakeries and other industries. The Company has a total annual capacity of 240 thousand tonnes per annum of sodium bicarbonate in India and the UK. The company owns Asia's largest saltworks, the world's third largest soda ash manufacturer, and the world's sixth largest sodium bicarbonate manufacturer. With its subsidiary company Rallis India Ltd, the corporation has a prominent position in the crop protection market.

Company Headquarters: Colombo, Sri Lanka Founded: 1973 Workforce: ~ 1,411 Company Working: Haycarb (Pvt) Ltd (Haycarb), together with its subsidiaries, is into the manufacturing and marketing of coconut shell activated carbon in Sri Lanka and globally. It is one of the largest companies operating in the coconut shell activated carbon industry. It primarily operates through two segments, namely activated carbon and environmentally engineering. Under the activated carbon segment, it offers various forms of activated carbon that are used in water treatment. It has a global sales network in the US, China, South Korea, Japan, Thailand, Indonesia, Australia, Sri Lanka, South Africa, and some countries in Europe.

Company Headquarters: Osaka, Japan Founded: 1949 Workforce: ~ 400 Company Working: Osaka Gas Chemicals Co., Ltd (Osaka) is a specialty chemicals company that manufactures and sells materials and solutions based on coal chemistry and medical technologies. It operates through various segments, namely activated carbon and its application products, carbon fiber and its application products, fine materials, resin additives, battery materials, preservatives, and processing. Under the activated carbon and its application products segment, it offers activated carbon that is used in the purification processes in food, alcohol and pharmaceutical manufacturing, air purifiers, and water filters. It held assets worth USD 16,815 million in 2017. It is a wholly owned subsidiary of Osaka Gas Co., Ltd.

Company Headquarters: Humlebaek, Denmark Founded: 1954 Workforce: ~11,000 Company Working: Coloplast Corp. (Coloplast) is a medical device company that develops and markets healthcare products and services across the world. The company functions through three operating segments, namely, chronic care, interventional urology, and wound and skin care. It provides medical devices for ostomy care, continence care products, wound care products, and products for the surgical treatment of urological and gynecological disorders. Coloplast markets and sells its products and services globally. Products are supplied to hospitals, institutions as well as wholesalers, distributors, and pharmacies. In selected markets, it is also a direct supplier to users. It has wholly-owned sales subsidiaries in its principal markets and employed about 12,000 people at the end of 2018.

Doosan Corporation, founded in 1896 and headquartered in Seoul, South Korea, operates as one of the oldest and most diversified industrial conglomerates in Asia. The group's relevance to the heavy equipment and utility vehicles market is anchored primarily through Doosan Bobcat — a wholly owned subsidiary and a globally recognized manufacturer of compact construction equipment, utility vehicles, and attachments. Doosan Bobcat operates manufacturing facilities across the United States, Europe, and Asia, distributing products through a dealer network spanning over 100 countries. The parent holding company, Doosan Corporation, is listed on the Korea Exchange and oversees a portfolio of businesses ranging from industrial machinery to power systems, with heavy equipment representing one of its highest-revenue segments. Doosan Bobcat forms the core of Doosan's competitive positioning in the heavy equipment and utility vehicles market. The subsidiary's product portfolio includes skid-steer loaders, compact track loaders, mini excavators, telescopic handlers, and a broad range of utility vehicles — most notably the Bobcat UV series used in agriculture, construction, landscaping, and municipal applications. Bobcat competes directly with Caterpillar, John Deere, and Manitou in the compact equipment segment, differentiating through dealer density, attachment versatility, and a strong aftermarket parts and service network. In the utility vehicle segment, Bobcat's UV34 and UV34XL models target professional-grade users in turf management, facility maintenance, and light construction, competing against Polaris Professional and Kubota RTV lines. Doosan Bobcat has pursued a strategy of product line expansion and electrification to address evolving regulatory and customer demands. The company unveiled its all-electric compact track loader and electric mini excavator concepts at major trade events including ConExpo, signaling a deliberate push into zero-emission equipment. In 2022, Doosan Bobcat completed its listing on the Korea Exchange as an independent entity, raising capital to fund R&D and geographic expansion — particularly in Europe and emerging markets where compact equipment adoption is accelerating. The parent Doosan Corporation has also restructured its broader portfolio following financial difficulties in 2020–2021, divesting non-core assets to sharpen focus on high-margin industrial and equipment businesses. Doosan Bobcat reported revenues of approximately KRW 7.8 trillion (roughly $5.9 billion USD) for fiscal year 2023, driven by sustained demand in North American construction and rental markets. The North American market accounts for the majority of Bobcat's equipment sales, with rental fleet operators — including United Rentals and Sunbelt Rentals — representing significant volume customers for skid-steer loaders and compact track loaders. Bobcat holds a leading share in the North American skid-steer loader segment, a position built over decades of brand recognition and an extensive dealer footprint exceeding 700 locations in the United States alone.

Company Headquarters: North Carolina, US Founded: 1993 Workforce: ~8,800 Company Working: Martin Marietta Materials, LLC (Martin Marietta) produces and distributes high-purity magnesium hydroxide and dolomitic lime used worldwide in environmental, industrial, agricultural, and specialty chemical applications. It operates through Mid-America Group, Southeast Group, West Group, Materials Business, and Magnesia Specialties. The company offers magnesium hydroxide through its magnesia specialties segment. Its MagChem product line offers magnesium hydroxide used in leather tanning, drilling fluids, cement, and mining applications. Further, it is a leading supplier of aggregates and heavy side building materials used in infrastructure, nonresidential, and residential construction projects. It has operations in 27 states of the US, have two magnesia specialty chemical plants, nine asphalt plants, and two cement plants.

Polyplastics is one of the world's most specialised engineering-thermoplastics franchises. For six decades it has been the vehicle through which Daicel competes in high-reliability resins. Its portfolio centres on DURACON polyacetal (POM), LAPEROS liquid crystal polymer (LCP) and TOPAS cyclic olefin copolymer (COC). In company literature it claims the leading global market share in all three. DURANEX PBT, DURAFIDE PPS, PET, long-fibre thermoplastics, fine powders and newer polyetherketone grades complement them. Its moat is application engineering: a global network of Technical Solution Centers co-designs parts with automotive, electronics and medical customers, which makes its resins hard to displace once specified. Since April 2026 the business has been folded into Daicel as the HPPs SBU, Daicel's largest unit by revenue. Its near-term story pairs AI-server-driven LCP demand and Chinese POM capacity growth against a costly, impaired German COC expansion. --- ### What the business does Polyplastics develops, polymerises, compounds and sells engineering thermoplastics. These are resins that sit between commodity plastics and super-engineering polymers on performance and price. Its products substitute for metal and for lower-grade plastics in parts that need dimensional stability, wear and sliding resistance, heat resistance, chemical resistance, purity or optical clarity. Typical end parts include gears, fuel-system and pump components, seat-belt and door-lock mechanisms, electrical connectors, sockets, camera modules, server and high-speed connectors, IC trays and wafer carriers, pre-filled syringes and insulin pens, and food-contact and medical films. ### Business model and revenue model | Revenue type | Approx. share | Basis | |---|---|---| | Product (resin and compound sales) | Substantially all | Segment description; no service revenue line reported | | Service (technical support, recompounding) | Not separately disclosed | Bundled | | Subscription | None | — | | Licensing / agency | Not separately disclosed (Mitsui marketing contract from 2026) | Mitsui Chemicals release 27 Oct 2025 | Revenue is almost entirely product sales of resins and compounds. Most grades are formulated for specific applications, and pricing is negotiated per grade. Raw-material pass-through clauses are used where obtainable: Daicel cited price revisions in Q1 FY2027. The service elements are mostly bundled rather than separately monetised: **Technical service / CAE / mould-flow and design support:** through Technical Solution Centers. Envalith's reading of the Daicel yuho cites five overseas TSCs. **DURACIRCLE:** re-compounding service, launched 2023. It recycles customers' in-plant scrap back into usable compound. **Third-party marketing:** Since 1 January 2026 the business markets Mitsui Chemicals' ARLEN (PA6T) and AURUM (thermoplastic polyimide). Mitsui keeps R&D, manufacturing and logistics. The economics are a consignment/agency arrangement, and the terms are not publicly disclosed. ### Value-chain position The business is integrated from monomer and polymer to compound. POM is polymerised at Fuji (Japan), Kaohsiung (Taiwan), Kuantan (Malaysia) and Nantong (China). LCP is polymerised in Taiwan (new 5,000 t/y plant, Feb 2025) and Japan. COC is polymerised in Oberhausen (Germany), with Leuna under construction. Compounding is regionalised. Upstream, POM benefits from Daicel's methanol- and formaldehyde-adjacent acetyl chain, which Daicel cites as a reason for the 2026 integration with its Materials SBU. Downstream, the business sells to Tier-1/Tier-2 moulders and directly to OEMs. ### Customer types and end-markets Customers are injection moulders, Tier-1 automotive suppliers, electronics component makers (connector and module makers), medical-device and pharma packaging converters, and film producers. The company itself describes end-markets as mobility, electrical and electronics, consumer goods, healthcare and industrial (chemXplore; company boilerplate). Daicel's integrated reports describe the business as serving automotive and electronics primarily, with global technical support and rapid delivery. ### Company's own description vs. independent characterisation - **Company description (paraphrased from boilerplate in releases, 2023–2025):** a global leader in engineering thermoplastics with a portfolio of POM, PBT, PPS, LCP, PET, COC and LFT; the largest global share in POM, LCP and COC; and more than 60 years of experience backed by a global R&D, production and sales network. **Independent characterisation:** Polyplastics is a mid-scale, application-engineering-led specialty resins producer. Group segment sales are roughly JPY 250 billion, or about USD 1.7 billion at JPY 150/USD. It is highly concentrated in POM by volume and differentiated in LCP and COC by margin. Profitability is cyclical with automotive builds and electronics inventory cycles: segment operating margin ranged from 7.5% to 10.9% over FY2022–FY2026. It is now carrying a stranded-asset problem in COC. Its biggest structural opportunity is LCP for high-speed data transmission in AI servers. The share claims for POM and LCP are plausible; for COC the company is the main merchant producer outside Japan's COP makers. None of the share claims could be independently verified from third-party market data in this research.

| Metric | FY2023 | FY2024 | FY2025 | FY2026 | |---|---|---|---|---| | Employees (approx., headcount) | 9000 | 9000 | 8700 | 8400 | Note: FY2023–FY2025 are approximations from company communications; the FY2025 figure is an interpolation and should be treated as not publicly verified. FY2026 (~8,400) is stated in every 2026 Solvay press release. The FY2025 media presentation references a workforce trajectory toward ~9,000 "by 2027" in a context that could not be fully parsed. Solvay is a 163-year-old Belgian producer of essential, largely commoditised inorganic and mid-chain chemicals whose franchise rests on scale, cost position and process know-how rather than proprietary molecules. Post-demerger, the group is anchored by two global leaderships — soda ash and its derivatives (including sodium bicarbonate) and hydrogen peroxide — complemented by highly dispersible silica for fuel-efficient tyres, the Brazil-based Coatis phenol/solvents chain, and a Special Chem unit housing rare earths and fluorine. With €4.3 billion of underlying sales and an EBITDA margin that has stayed above 20% through a severe soda ash downcycle, Solvay positions itself as a cash-generating, dividend-paying "essential chemistry" company. Its equity story now pivots on three levers: structural cost reduction (€300 million cumulative by end-2026), decarbonisation of coal-fired soda ash plants, and optionality in Western rare earths separation at La Rochelle — an asset increasingly seen as strategic outside China. --- ### Company's own description Solvay describes itself as "a pioneering chemical company with a legacy rooted in founder Ernest Solvay's pivotal innovations in the soda ash process," delivering essential solutions that address needs such as purifying air and water, preserving food, protecting health, making tyres more sustainable, and cleaning and protecting homes. Its corporate purpose, as presented with FY2025 results, is "essential chemistry, making progress possible for generations," executed through four strategic levers: operational excellence, energy transition, process innovation and production capacity (Source: FY2025 media presentation, 24 Feb 2026). ### Independent characterisation Solvay is today a mid-cap, cyclical, largely B2B commodity and intermediate chemicals producer. Roughly 60% of sales and around two-thirds of segment EBITDA come from Basic Chemicals (soda ash, bicarbonate, peroxides), where pricing is set by global supply-demand balances — notably the seaborne soda ash market, which has been depressed by Chinese and Turkish capacity additions. The remaining ~40% of sales (Performance Chemicals) are more differentiated (silica for tyres, rare earths formulations, autocatalyst materials, fluorine specialties, phenol/solvent chain) but smaller and more volatile in margin. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue mix | ~100% product sales; no material service, subscription or licensing revenue disclosed. Minor technology/licensing elements exist (e.g., samarium process technology supplied to Permag, 2025) but are not separately reported | | Contract structure | Soda ash: largely annual contracts in Europe/US, spot/short-term in seaborne Asia; peroxides: long-term on-site/captive supply to HPPO (propylene oxide) plants plus merchant sales; silica: multi-year qualifications with tyre makers | | Value chain position | Upstream/mid-stream: converts salt, limestone, trona, hydrogen, natural gas/energy and mineral concentrates into base inorganic chemicals and intermediates | | Cost drivers | Energy (gas, coal, power), CO2 allowances (EU ETS), freight, raw materials (limestone, salt, trona, ore concentrates), fixed costs | | Customer types | Glass manufacturers (flat, container, solar), detergent producers, chemical companies, tyre makers, pulp & paper, electronics/semiconductor fabs, food/feed/pharma, flue gas treatment operators, mining, automotive catalysts, magnet makers | | End-markets | Construction and automotive glass, solar glass, consumer goods (detergents), food & pharma (bicarbonate), environment (flue gas treatment, water), semiconductors (electronic-grade H2O2), mobility (tyres, catalysts, EV magnets), agro and coatings (solvents) | ### Segment business descriptions (as defined by Solvay) **Basic Chemicals:** Soda Ash & Derivatives and Peroxides businesses. **Performance Chemicals:** Coatis, Silica and Special Chem businesses (Source: Q1/Q2/FY2025 media presentations). **Corporate & Business Services:** corporate functions, energy services and other.

Koppers is a vertically integrated, mid-cap industrial materials company that sits at the intersection of three unglamorous but essential infrastructure value chains: North American rail track maintenance, electric-utility pole replacement, and wood-preservation chemistry. Its competitive identity rests on integration — coal-tar distillation supplies creosote to its own crosstie treating plants, and its copper-based preservative business supplies its own utility pole plants — giving it security of supply and cost advantages that pure treaters lack. Management believes it is the largest supplier of crossties to North American Class I railroads, the second-largest US utility pole producer, the largest Australian pole supplier, and the global leader in wood-preservation chemicals (10-K FY2025). The company is mid-way through "Catalyst," a cost and portfolio transformation that delivered ~USD 46M of benefits in FY2025, while exiting structurally challenged carbon assets. Leverage (~3.4–3.5x net debt/adj. EBITDA) and cyclical end-markets remain the core investment debate. --- ### Company's own description (FY2025 10-K, paraphrased) Koppers describes itself as a leading integrated global provider of treated wood products, wood preservation chemicals and carbon compounds, serving niche applications across railroad, specialty chemical, utility, residential lumber, agriculture, aluminium, steel, rubber and construction end-markets, through manufacturing capabilities in North America, South America, Australasia and Europe. It reports three segments: Railroad and Utility Products and Services (RUPS), Performance Chemicals (PC), and Carbon Materials and Chemicals (CMC). The 10-K emphasises two integration loops: CMC converts coal tar into creosote, most of which (in North America and Europe) is consumed internally by RUPS; and PC produces CCA and DCOI, a portion of which is sold internally to RUPS for pole and piling treatment. ### Business model and revenue model | Revenue type | Where it sits | Description | Disclosure status | |---|---|---|---| | Manufactured products | All segments | Treated crossties, utility poles, pilings, preservatives, fire retardants, pitch, creosote, naphthalene, carbon black feedstock | Majority of revenue; exact split NR | | Wood-treating services | RUPS | Treating customer-owned ties ("service revenue … recognised at time of treatment") | Recognised separately in revenue policy; amount NR | | Untreated wood procurement | RUPS | Procurement of untreated crossties, recognised on delivery to plant | Amount NR | | Field/maintenance-of-way services | RUPS | Utility pole inspection; tie recovery/disposal; railroad bridge services (divested Aug 2025) | Amount NR | | Royalty / licensing | PC | Royalty income on preservative technologies (cited as Q4 FY2025 EBITDA support) | Amount NR | Koppers is overwhelmingly a product business, with a minority service component and a small licensing/royalty stream: Subscription revenue: none. Approximately 75% of North American Railroad Products and Services sales are under long-term contracts (10-K FY2025). ### Value-chain position **Upstream inputs:** hardwood lumber from hundreds of small sawmills (~70% of a finished crosstie's cost); pine and eucalyptus poles; ~30 million lb/year of scrap copper; coal tar (a by-product of coke-making) under 1–4 year supply contracts (10-K FY2025). **Midstream conversion:** coal-tar distillation (3 facilities at end-2025, falling to 2 after Stickney closure), copper compound manufacture (Hubbell, MI; Millington, TN), 18 wood-treating plants plus one rail joint bar facility (10-K FY2025). **Downstream:** direct sales to Class I and short-line railroads, investor-owned and municipal utilities, lumber treaters (PC supplies 10 of the 11 largest US treaters), aluminium smelters, steelmakers, carbon black producers and concrete admixture makers. ### Customer types and concentration No single customer exceeded 6% of FY2025 net sales; top ten customers ~36% (10-K FY2025). Koppers supplies all North American Class I railroads; Class Is purchase ~70% of all crossties produced in the US and Canada. The US utility pole business serves eight of the top ten US utilities. ### End-markets served Railroad maintenance (crossties, switch ties, bridge and crossing timbers, joint bars); electric and telecom utility distribution/transmission poles (US, Australia); residential decking/fencing and construction lumber (via PC preservatives); commercial construction (FlamePro fire retardant); agriculture (vineyard and landscape poles; ag treatments); aluminium smelting and steel (carbon pitch); carbon black (feedstock); concrete (naphthalene-based superplasticiser precursor); emerging battery anode materials (CPRO, marketed on company website). ### Independent characterisation Koppers is best understood as two decent businesses plus one structurally challenged one. RUPS is a scale, logistics-driven treater with plants on customers' rail lines, now benefiting from utility grid investment but facing Class I volume pullbacks and price erosion. PC is the highest-margin franchise (18–22% adj. EBITDA margin in FY2023–FY2025) with proprietary micronised-copper technology and brand equity (MicroPro), but it is exposed to residential repair-and-remodel cycles and lost US share in FY2025 before regaining volume in H1 2026. CMC is a shrinking, commoditised coal-tar distiller whose margin collapsed to 1–7% in H1 2026; management is shrinking it aggressively (phthalic anhydride exit in 2025; Stickney distillation closure in 2026). The equity story is therefore a self-help, cash-flow and deleveraging story rather than a growth story.

Mitsubishi Chemical Corporation is the chemicals engine of Japan's largest diversified chemical group, Mitsubishi Chemical Group. Following the July 2025 sale of Mitsubishi Tanabe Pharma to Bain Capital for roughly JPY 510 billion, the group has narrowed to two pillars: chemicals (run through MCC) and industrial gases (run through ~50%-owned, separately listed Nippon Sanso Holdings). MCC operates three reporting segments — Specialty Materials (engineering plastics, films, carbon fiber composites, semiconductor process materials and services, food-packaging polymers), MMA & Derivatives (a global leader in methyl methacrylate and PMMA) and Basic Materials & Polymers (ethylene, polyolefins, coal chemicals). Under "KAITEKI Vision 35" and the Medium-Term Management Plan 2029, management is pursuing a "Green Specialty" identity: harvesting and restructuring commoditised petrochemical, coke and MMA assets while investing in semiconductor, mobility and food-preservation materials. FY2025 profits were depressed by restructuring charges, but Q1 FY2026 core operating income more than doubled year-on-year. --- ### What the company does Mitsubishi Chemical Group is a holding company whose consolidated revenue (JPY 3,704.0bn in FY2025) comes from four reportable segments. Three are operated by Mitsubishi Chemical Corporation (Specialty Materials; MMA & Derivatives; Basic Materials & Polymers), and the fourth (Industrial Gases) is operated by Nippon Sanso Holdings and its subsidiaries (Taiyo Nippon Sanso in Japan, Matheson Tri-Gas in the US, Nippon Gases in Europe, plus Asia-Oceania operations including Coregas in Australia/New Zealand from July 2025). The former Pharma segment was reclassified as discontinued operations after the transfer of Mitsubishi Tanabe Pharma's business on 1 July 2025. FY2025 segment revenue mix (Yuho FY2025, external revenue basis per EDINET-derived data): Industrial Gases ~37–38%, Specialty Materials ~29–30%, Basic Materials & Polymers ~21–22%, MMA & Derivatives ~10%. The striking feature of the current profile is the asymmetry between revenue and profit: Industrial Gases delivered JPY 200.7bn of the group's JPY 225.0bn FY2025 core operating income (~89%), while the three MCC-run chemical segments combined (including corporate/other) contributed only JPY 24.3bn. MCC's investment case therefore rests on restoring chemical-segment profitability, which management guides to JPY 100bn in FY2026. ### Business and revenue model | Dimension | Characterisation | |---|---| | Product vs. service | Overwhelmingly product sales (materials and chemicals sold by volume/weight under spot, formula-linked and contract pricing). Service elements exist in Specialty Materials (e.g., precision cleaning services for semiconductor equipment parts) and in Industrial Gases (on-site supply, cylinder rental, equipment and engineering) | | Subscription / licensing | Minor. Technology licensing exists (e.g., MMA process technology, including the Alpha ethylene-based MMA process originally from Lucite), but licensing revenue is not separately disclosed | | Pricing mechanics | Commodity segments (MMA, olefins, polyolefins, coke) are spread-driven (product price minus naphtha/feedstock cost) and exposed to inventory valuation gains/losses. Specialty segments are value-priced; MTP 2029 explicitly emphasises pricing to "true value" delivered. Industrial gases are largely long-term contracts with energy pass-through | | Value-chain position | Vertically integrated from naphtha cracking (Kashima; Mizushima via the Asahi Kasei JV) and coal chemicals through monomers (MMA, acrylonitrile historically) to polymers, films, composites and fabricated parts | ### Customer types and end-markets Customers are predominantly B2B manufacturers: semiconductor device makers and equipment OEMs; display and electronics makers; automotive OEMs and Tier-1s (including electric-vehicle and robotaxi programmes); food and beverage packaging converters; medical/cell-culture device makers; construction and coatings formulators; and steelmakers (coke, industrial gases). End-markets highlighted by management in FY2025: semiconductors (precision cleaning, high-performance engineering plastics for semiconductor manufacturing equipment, synthetic quartz, GaN substrates), mobility (carbon-fibre composite parts, DURABIO bio-based polycarbonate — adopted by Audi for Q3 door-switch inserts in June 2026), food quality preservation (Soarnol EVOH barrier resin, films), healthcare/life sciences, and AI data-centre optical interconnects (investment in NLM Photonics, 2026). ### Company's own description vs. independent characterisation The group describes itself under KAITEKI Vision 35 as aiming to become a "Green Specialty Company," with CEO Chikumoto framing the current phase as a return to "fundamentals-focused" management — clear profit responsibility for every business and a "lean and strong" organisation (Nomura Asset Management interview, 2025–26). Independent characterisation: In practice MCG today is a gases-funded chemical restructuring story. A high-quality, mid-teens-margin industrial-gas annuity (consolidated but ~50% minority-owned) masks a chemical portfolio that in FY2025 earned a low-single-digit core margin and booked roughly JPY 195bn of non-recurring losses (core-to-reported operating income bridge). The equity story hinges on (a) Specialty Materials compounding from JPY 23.9bn (FY2024) toward management's JPY 144bn FY2029 ambition, (b) the MMA cycle bottoming, and (c) completing the exit or consolidation of structurally challenged commodity assets (coke, Mizushima ethylene, basic petrochemicals spin-off).

Company Headquarters: US Founded: 1993 Workforce: 4,400 Company Working: Cytec Industries, Inc. (Cytec) is one of the leading developers, manufacturers, and distributors of composites and specialty materials. The products offered by Cytec serve a wide range of end users such as aerospace and industrial materials, plastics, and mining. It operates through four business segments, namely, aerospace materials, industrial materials, in process separation, and additive technologies. The company manufactures and sells various high-performance grades of standard modulus PAN and pitch-based carbon fibers that are primarily used as reinforcement material for aerospace and other high-performance composites. Cytec utilizes around 89% of its carbon fiber production and sells the balance to third parties.

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} 1.1.1 COMPANY OVERVIEW Company Headquarters: Netherlands Founded: 1998 Workforce: ~133,671 Company Working: Airbus SAS (Airbus) is a leading manufacturer of civil, commercial, and military aircraft, space missiles, and satellites. The company has production houses in the Netherlands, France, Germany, Spain, China, the UK, and the US. The company also has subsidiaries in the US, China, Japan, Saudi Arabia, and India with more than 150 sales offices around the world. Its spare parts centers are in Hamburg, Frankfurt, Washington, DC, Dubai, Beijing, and Singapore. Airbus operates through three major business segments, namely Airbus commercial aircraft, Airbus defense and space, and Airbus helicopters. The Airbus commercial aircraft segment is the highest revenue-generating segment and includes aircraft manufacturing and related systems and services. The Airbus helicopters segment deals with the development, manufacture, marketing, and sale of civil and military helicopters as well as helicopter MRO services. The Airbus defense and space segment covers systems and services in the field of defense and space for governments, institutions, and commercial customers.

Company Headquarters: US Founded: 1887 Workforce: ~ 10,000 Company Working: H.B. Fuller Company (H.B. Fuller) is a pioneer leader who designs, manufactures, and sells sealants, adhesives, and other chemical products, globally. It operates mainly through five business segments, namely, Americas Adhesives, EIMEA, Asia Pacific, construction adhesives, and engineering adhesives. The company offers its products for applications in medical, construction, electronics, energy, transportation, and other industrial sectors. Grouts, sealants, and other related products are offered by the company. Moreover, it offers its products and solutions through various brands, such as Advantra, Clean Melt, EternaBond, and Sesame. H.B. Fuller has its presence in more than 30 countries of the Americas, Europe, the Middle East & Africa, and Asia-Pacific. It has its operation in countries such as the US, the UK, Spain, France, Germany, Czech Republic, Italy, Portugal, Egypt, the UAE, India, and Australia. Ramapo Sales and Marketing, Inc. and Dalton Holdings, LLC, are a few of its subsidiaries.

Company Headquarters: Beijing, China Founded: 1998 Workforce: ~ 5,82,648 Company Working: China Petrochemical Corporation (Sinopec) is a vertically integrated energy and chemical company. This corporation manufactures, markets, stores, and moves petrochemicals, chemical fibers, chemical fertilizers, and other chemical products. Additionally, it takes part in activities including oil and gas exploration, production, extraction, marketing, and oil refining. The company also works as an import and export agency for commodities such as crude oil, natural gas, refined oil products, petrochemicals, chemicals, and other technologies. It also conducts research, development, and application of technology and information. Its product line includes petrochemical products like synthetic resin, synthetic fiber monomers & polymers, synthetic rubber, synthetic fiber, chemical fertilizers, lubricants, and petrochemical intermediates in addition to refined oil products like petrol, diesel, and jet fuel. The business also exports pressure vessels, cables, seamless pipes, drilling and fracturing equipment, and other goods. The company has operations in 23 nations, including Singapore and China.

Celanese is a US-headquartered chemical and specialty materials company with two businesses. Engineered Materials sells specialty polymers such as POM, nylon, PBT, LCP, UHMW-PE and elastomers into automotive, electronics, medical and industrial applications. The Acetyl Chain is among the world's largest and lowest-cost producers of acetic acid, vinyl acetate monomer and their downstream derivatives. The USD 11 billion acquisition of DuPont's Mobility & Materials business in 2022 doubled the engineered-materials franchise but left the company with about USD 12.6 billion of debt just as demand weakened. That has produced two consecutive years of multi-billion-dollar goodwill and trade-name impairments, a 95% dividend cut and the loss of investment-grade ratings. Under CEO Scott Richardson, in post since January 2025, the agenda is cash generation, cost reduction, divestitures and footprint closures. The equity is a highly leveraged recovery situation: second-quarter 2026 earnings were the strongest in nearly three years, helped partly by temporary supply dislocations. --- **The company's own description (paraphrased from the FY2025 10-K, Item 1).** Celanese describes itself as a global chemical and specialty materials company. It is a global producer of high-performance engineered polymers and one of the world's largest producers of acetyl products, which are intermediates for nearly all major industries. Its end-uses include automotive, chemical additives, construction, adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles. It attributes its leading positions to differentiated business models, large global capacity, operating efficiency, proprietary technology and a competitive cost structure. Operations comprise 51 production facilities plus 20 strategic-affiliate production facilities, mainly in North America, Europe and Asia. **Independent characterisation.** Celanese is best understood as two distinct businesses under one leveraged balance sheet: 1. **Acetyl Chain (44% of FY2025 net sales).** This is an integrated commodity-to-intermediate chain: methanol, acetic acid, VAM, then emulsions, redispersible powders and EVA polymers, plus acetate tow. Its advantage is cost position, built on US Gulf Coast natural gas, the Clear Lake complex, the Fairway methanol joint venture and proprietary AOPlus and VAntage process technologies. It also has the optionality to move molecules between products and regions to wherever margin is highest. Pricing follows industry utilisation and raw-material costs, with lags of months to quarters. 2. **Engineered Materials (56% of FY2025 net sales).** This is a project-based specialty polymers business. Materials are specified into customer parts through an opportunity pipeline. Pricing is primarily value-in-use and largely independent of raw-material cost in the short run, so margins expand or contract as input costs move. **Revenue model.** Revenue is essentially 100% product sales, covering chemicals and polymers sold by volume. There is no material subscription, service or licensing revenue line, although process technology has been licensed historically. A significant share of earnings comes from non-consolidated affiliates. In FY2025, equity in net earnings of affiliates was USD 127 million and dividend income from cost-method investments was USD 122 million, mainly from the three Chinese acetate tow ventures with China National Tobacco Corporation (FY2025 earnings release). **Value chain position.** The company is upstream-integrated in acetyls, with self-supply of methanol in North America through Fairway and captive acetic acid, VAM and formaldehyde. In Engineered Materials it is midstream, covering polymerisation and compounding. It sells to OEMs, tier suppliers, moulders, formulators and distributors. **Customer types.** Engineered Materials sells to OEMs and their suppliers in automotive, medical, industrial and consumer markets under multi-year and annual arrangements, plus distributors. The Acetyl Chain sells to producers of paints, coatings, adhesives, polyesters, pharmaceuticals and construction products under a mix of short- and long-term agreements. Acetate tow is sold to the major tobacco companies, often on multi-year pricing. **End-markets.** Automotive (including electric and hybrid drivetrains), electrical and electronics (connectors, AI-server components), medical devices and drug delivery, construction, paints and coatings, adhesives, packaging, filtration (cigarette filters), energy storage (battery separators) and consumer goods.

### Key facts | Item | Detail | |---|---| | Legal name | Wacker Chemie AG | | Former names | Dr. Alexander Wacker Gesellschaft für elektrochemische Industrie (founding entity, 1914); Wacker-Chemie GmbH (GmbH form used for most of the 20th century; converted to AG in 2005 ahead of the IPO) | | Founded | 1914, by Dr. Alexander Wacker. The Burghausen plant began operating during World War I. | | Incorporation jurisdiction | Federal Republic of Germany (Aktiengesellschaft; two-tier board under the German Stock Corporation Act) | | Headquarters | WACKER House, Werksviertel district, Munich. Address on 2026 press releases: Gisela-Stein-Straße 1, 81671 Munich. The previous HQ address, Hanns-Seidel-Platz 4, 81737 Munich, still appears in some third-party directories. | | Stock exchange / tickers | Frankfurt Stock Exchange (Xetra): WCH. Bloomberg: WCH GR. Reuters: WCHG.DE. US OTC (unsponsored): WKCMF | | ISIN / WKN | DE000WCH8881 / WCH888 | | CUSIP | None. There is no SEC registration and no sponsored ADR. | | IPO | 10 April 2006 | | Share capital | EUR 260,763,000, split into 52,152,600 bearer shares. Of these, 49,677,983 are outstanding (excluding treasury) and 2,474,617 are treasury shares (about 4.7%). | | Fiscal year end | 31 December | | Employees (31 Dec) | 2025: 16,467; 2024: 16,637; 2023: 16,378; 2022: 15,725 | | German workforce (2025) | 10,749 employees in Germany; 5,718 abroad | | Auditor | PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft. PwC gave an unqualified opinion on the FY2025 consolidated statements (AR2025, Executive Board declaration). The previous long-standing auditor was KPMG. | | Market capitalisation | EUR 3,445.2M at 31 Dec 2025 (EUR 69.35 per share; AR2025). About EUR 4.34bn at EUR 87.45 on 13 Sep 2026 (derived: 49.68M outstanding shares × price). Some data vendors quote about EUR 4.5–4.7bn using the total share count including treasury shares. | | Credit rating | None published. Wacker states it relies on bank credit lines and promissory notes (Schuldschein) and does not issue rated instruments (AR2025). | | Website | www.wacker.com | | Business divisions | Silicones, Polymers, Biosolutions, Polysilicon | | FY2025 headline figures | Sales EUR 5,485.3M; reported EBITDA EUR 426.7M; EBITDA before special items about EUR 529M; net result EUR -804.9M; no dividend | Wacker Chemie is a Munich-headquartered, family-controlled, integrated chemicals group. Its two root raw materials are metallurgical silicon and ethylene. From these it builds four businesses: **Silicones:** This is about half of group sales and is one of the world's broadest silicone portfolios. **Polymers:** This division is a global leader in vinyl acetate-ethylene (VAE) dispersions and dispersible polymer powders, sold mainly into construction. **Polysilicon:** This division supplies hyperpure semiconductor- and solar-grade silicon from Burghausen, Nünchritz and Charleston (USA). **Biosolutions:** This is a smaller biotech and contract-manufacturing (CDMO) unit spanning fermentation products, cyclodextrins, proteins and mRNA. The group's strengths are process integration in a closed chlorine-silicon loop, deep application know-how and a German-centred asset base. That same German base is now its principal weakness. High energy costs, Chinese overcapacity in silicones and polysilicon, and weak construction demand drove a EUR -805M net loss in FY2025. Management's response is the PACE programme, targeting more than EUR 300M of annual cost savings by 2027. It is paired with a pivot toward specialties, semiconductor-grade polysilicon and biotech. --- ### What the company does Wacker converts two feedstock chains into intermediate and specialty materials sold business-to-business. 1. **The silicon chain.** Metallurgical silicon is converted into chlorosilanes, then into siloxanes and silicones, pyrogenic (fumed) silica, and hyperpure polysilicon. 2. **The ethylene chain.** Ethylene and acetic acid are converted into vinyl acetate monomer (VAM), then into VAE dispersions, dispersible polymer powders, and solid resins. The defining feature is integration. By-products of one step are feedstocks for another, especially in the silicon/chlorine and hydrogen-chloride loops at Burghausen and Nünchritz. This supports cost position and resource efficiency, but it also creates high fixed costs and utilisation sensitivity. Management repeatedly cites low plant utilisation as a FY2025 earnings drag (FY2025 press release). ### The company's own description (paraphrased from AR2025 and releases) Wacker describes itself as a globally active chemical company with four business divisions. It develops and manufactures products, intermediates and technologies for virtually all key industries. It positions its chemical divisions on specialties, its polysilicon division on the semiconductor market, and Biosolutions on biotech solutions. This three-part strategic focus was articulated by CEO Christian Hartel at the FY2025 annual press conference (11 Mar 2026). ### Independent characterisation Wacker is best understood as a cyclical, energy-intensive, process-integrated materials company carrying a growing specialty overlay. Commodity exposure remains material in three places: - standard silicones (siloxanes and fluids); - solar-grade polysilicon; - part of the VAE and powders business. These are precisely where Chinese capacity additions have destroyed pricing. The specialty overlay is real but not yet dominant. Examples include: - liquid silicone rubber (LSR); - medical-grade and electronics silicones; - silane-terminated polymers; - semiconductor-grade polysilicon; - biologics CDMO. The FY2022 peak (EBITDA EUR 2.08bn, 25.4% margin) and the FY2025 trough (reported EBITDA EUR 427M, 7.8% margin) show an earnings amplitude typical of commodity chemicals rather than specialty peers. ### Revenue model | Revenue type | Approximate share | Description | |---|---|---| | Product sales (chemicals and materials) | About 97% (derived: everything except Biosolutions' service component) | Spot and contract sales of silicones, polymers and polysilicon. Polysilicon historically relied on multi-year supply agreements with prepayments, especially for solar. | | Contract manufacturing services (CDMO) | Part of Biosolutions (division sales EUR 360.4M in FY2025, 6.6% of group); service share not separately disclosed | Fee-for-service development and GMP manufacture of biologics, mRNA, plasmid DNA and live biotherapeutics via Wacker Biotech (Jena, Halle, Amsterdam, León, San Diego) | | Licensing / subscription | Not material; not separately disclosed | Some process-technology know-how, not reported as a revenue line | | "Other" segment | EUR 142.2M in FY2025 (2.6%) | Infrastructure and site services, corporate items | ### Value-chain position **Upstream:** Wacker produces part of its own silicon metal at Holla, Norway. It buys the remainder, plus ethylene, methanol, acetic acid and energy (electricity and gas), largely in Germany. **Midstream (core):** Chlorosilanes, siloxanes, VAM and polysilicon. **Downstream:** Formulated specialty products sold to OEMs and formulators. Wacker does not generally sell to end consumers. ### Customer types and end-markets | End-market | Primary divisions | Key applications | |---|---|---| | Construction | Polymers, Silicones | Tile adhesives, self-levelling compounds, external insulation (ETICS), sealants, masonry protection, paints | | Automotive and transportation | Silicones | Gaskets, cables, EV battery thermal management, LSR parts | | Electrical and electronics | Silicones, Polysilicon | Encapsulants, potting compounds, high-voltage insulators, semiconductor wafers (via the Siltronic and other wafer customers) | | Semiconductors | Polysilicon | Hyperpure polysilicon for Czochralski (CZ) and float-zone (FZ) crystal pulling | | Solar / photovoltaics | Polysilicon | Solar-grade polysilicon | | Personal care and consumer goods | Silicones, Biosolutions | Emollients, hair-care silicones, cyclodextrins | | Textiles, paper, coatings | Silicones, Polymers | Release coatings, softeners, binders | | Medical and healthcare | Silicones, Biosolutions | Medical-grade silicones, pharmaceutical proteins, mRNA, vaccines | | Food and agriculture | Biosolutions, Polymers | Cysteine, gum-base resins (polyvinyl acetate), nutraceutical actives |